GUWAHATI: The Assam government has declared ‘black fungus’ as a notifiable disease, making it mandatory for all health facilities to report such cases.
India News: India on Tuesday posted 196,427 new coronavirus cases over the last 24 hours, its lowest daily rise in infections since April 14, while deaths from Co
Delhi High Court dismisses with Rs 25,000 cost plea for change in COVID treatment protocol
SECTIONS
Delhi High Court dismisses with Rs 25,000 cost plea for change in COVID treatment protocolPTI
Last Updated: May 25, 2021, 12:59 PM IST
Share
Synopsis
A bench of Chief Justice D N Patel and Justice Jyoti Singh declined to entertain the plea, moved by two doctors and two research analysts, which had claimed that use of antipyretics, like paracetamol, antibiotics and steroids should be restricted to severe cases of COVID-19 and not at the initial stage of the infection.
Agencies
The court said the instant plea was not a PIL, rather it was a publicity interest litigation and directed the petitioners to deposit the cost of Rs 25,000 within four weeks.
Synopsis
Health Minister Harsh Vardhan had said on Monday that 18 states have reported 5,424 cases of mucormycosis, a life-threatening infection, prevalent among COVID-19 patients and those who recovered from the viral disease.
AIIMS Director Randeep Guleria has also said that it is better to identify mucormycosis by its name rather than by the colour.
Amid rising mucormycosis cases among Covid patients and those who have recovered from it, epidemiologists Tuesday advised people to not get panicked by the colour of the fungus causing it, and underlined the importance of analysing the kind of infection, its causes and associated risk-factors.
Health Minister Harsh Vardhan had said on Monday that 18 states have reported 5,424 cases of mucormycosis, a life-threatening infection, prevalent among COVID-19 patients and those who recovered from the viral disease.
Maybe re-look advisory barring repeat of RTPCR on COVID positive patients: HC to ICMR
SECTIONS
Last Updated: May 25, 2021, 07:01 PM IST
Share
Synopsis
The suggestion by the court came while hearing a plea by a lawyer who has challenged the advisory as due to it, neither he nor his family members could get tested again after spending more than 17 days in quarantine from April 28 when they first tested positive.
The petition also seeks directions to the Delhi government to permit testing of the petitioner and his parents.
The Delhi High Court on Tuesday suggested to the Indian Council of Medical Research (ICMR) that it may need to re-look its recent advisory which said RTPCR must not be repeated on an individual who tested positive by either Rapid Antigen Test (RAT) or RTPCR. Justice Rekha Palli asked the counsel for ICMR to take instructions on the issue saying maybe you need to re-look your advisory .